Stocks and Investing
Stocks and Investing
Mon, August 2, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Geoffrey Porges Maintained (ABBV) at Buy with Increased Target to $145 on, Aug 2nd, 2021
Geoffrey Porges of SVB Leerink, Maintained "AbbVie Inc." (ABBV) at Buy with Increased Target from $144 to $145 on, Aug 2nd, 2021.
Geoffrey has made no other calls on ABBV in the last 4 months.
There are 5 other peers that have a rating on ABBV. Out of the 5 peers that are also analyzing ABBV, 0 agree with Geoffrey's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Geoffrey
- Robyn Karnauskas of "Truist Securities" Initiated at Strong Buy and Held Target at $118 on, Monday, July 26th, 2021
- Navin Jacob of "UBS" Maintained at Strong Buy with Increased Target to $126 on, Wednesday, May 12th, 2021
- Tim Anderson of "Wolfe Research" Maintained at Buy with Increased Target to $127 on, Monday, May 3rd, 2021
- Daniel Busby of "RBC Capital" Reiterated at Buy and Held Target at $135 on, Monday, May 3rd, 2021
- Gary Nachman of "BMO Capital" Maintained at Buy with Increased Target to $129 on, Monday, May 3rd, 2021
Contributing Sources